Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 May;82(9):2955–2959. doi: 10.1073/pnas.82.9.2955

Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer.

C L Finstad, C Cordon-Cardo, N H Bander, W F Whitmore, M R Melamed, L J Old
PMCID: PMC397685  PMID: 3857626

Abstract

Six mouse monoclonal antibodies (mAbs) defining separate systems of cell surface antigens of cultured human renal cancer were tested for reactivity with normal fetal and adult tissues and with neoplastic tissues. Five of the mAbs identified glycoproteins of Mr 160,000 (designated S4), Mr Mr 140,000 (F23), Mr 120,000 (S23 and S27), and Mr 115,000 (S22). The glycoprotein component of Mr 120,000 has been shown recently to be the adenosine deaminase binding protein (ADA-BP) and mAbS23 and mAbS27 define two distinct epitopes on ADA-BP. S22 was not detected on any normal fetal or adult tissues but was found on a subset of renal cancers. S4, F23, S23, and S27 defined distinct domains of the nephron: glomerulus (S4), proximal tubules (S4, F23, S23, and S27), and portions of Henle's loop (S23 and S27). mAbS4 also reacted with the interstitial matrix in the renal medulla and of other tissues, and mAbF23 reacted with fetal and adult fibroblasts. The S23 epitope of ADA-BP was expressed by placental trophoblasts and epithelial cells of breast, prostate, lung, and colon, whereas the S27 epitope was detected on a more limited range of cell types (trophoblasts and prostate epithelium). A panel of 20 renal cell carcinomas was typed for expression of these antigens; 7 phenotypes could be distinguished, with the S4+/F23+/S23+/S27+/S22+ or - phenotype (15 cases) being most common. The other antigenic system, V1, identified a heat-stable antigen that was widely expressed on cultured cell types but showed a restricted pattern of reactivity in tissues. V1 expression was limited to the adrenal cortex, Leydig cells, and the theca of ovarian follicles, and to adrenal cortical carcinomas.

Full text

PDF
2955

Images in this article

2956Image
on p.2956
2959Image
on p.2959

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andy R. J., Finstad C. L., Old L. J., Lloyd K. O., Kornfeld R. The antigen identified by a mouse monoclonal antibody raised against human renal cancer cells is the adenosine deaminase binding protein. J Biol Chem. 1984 Oct 25;259(20):12844–12849. [PubMed] [Google Scholar]
  2. Andy R. J., Kornfeld R. The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J Biol Chem. 1982 Jul 25;257(14):7922–7925. [PubMed] [Google Scholar]
  3. Cordon-Cardo C., Bander N. H., Fradet Y., Finstad C. L., Whitmore W. F., Lloyd K. O., Oettgen H. F., Melamed M. R., Old L. J. Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem. 1984 Oct;32(10):1035–1040. doi: 10.1177/32.10.6384360. [DOI] [PubMed] [Google Scholar]
  4. Dracopoli N. C., Rettig W. J., Goetzger T. A., Houghton A. N., Spengler B. A., Oettgen H. F., Biedler J. L., Old L. J. Three human cell surface antigen systems determined by genes on chromosome 12. Somat Cell Mol Genet. 1984 Sep;10(5):475–481. doi: 10.1007/BF01534852. [DOI] [PubMed] [Google Scholar]
  5. Erlandson R. A., Cardon-Cardo C., Higgins P. J. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol. 1984 Nov;8(11):803–820. doi: 10.1097/00000478-198411000-00001. [DOI] [PubMed] [Google Scholar]
  6. Farr A. G., Nakane P. K. Immunohistochemistry with enzyme labeled antibodies: a brief review. J Immunol Methods. 1981;47(2):129–144. doi: 10.1016/0022-1759(81)90114-9. [DOI] [PubMed] [Google Scholar]
  7. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gown A. M., Vogel A. M. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol. 1984 Feb;114(2):309–321. [PMC free article] [PubMed] [Google Scholar]
  9. Heppner G. H., Miller B. E. Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev. 1983;2(1):5–23. doi: 10.1007/BF00046903. [DOI] [PubMed] [Google Scholar]
  10. Herbschleb-Voogt E., Grzeschik K. H., Pearson P. L., Meera Khan P. Assignment of adenosine deaminase complexing protein (ADCP) gene(s) to human chromosome 2 in rodent-human somatic cell hybrids. Hum Genet. 1981;59(4):317–323. doi: 10.1007/BF00295464. [DOI] [PubMed] [Google Scholar]
  11. Holthöfer H., Miettinen A., Paasivuo R., Lehto V. P., Linder E., Alfthan O., Virtanen I. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest. 1983 Sep;49(3):317–326. [PubMed] [Google Scholar]
  12. Houghton A. N., Eisinger M., Albino A. P., Cairncross J. G., Old L. J. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med. 1982 Dec 1;156(6):1755–1766. doi: 10.1084/jem.156.6.1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. RIOPELLE J. L. The nature and origin of the so-called true kidney hypernephroma. Cancer. 1951 Jul;4(4):789–802. doi: 10.1002/1097-0142(195107)4:4<789::aid-cncr2820040416>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  14. Rettig W. J., Dracopoli N. C., Goetzger T. A., Spengler B. A., Biedler J. L., Oettgen H. F., Old L. J. Somatic cell genetic analysis of human cell surface antigens: chromosomal assignments and regulation of expression in rodent-human hybrid cells. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6437–6441. doi: 10.1073/pnas.81.20.6437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schrader W. P., Stacy A. R. Immunoassay of the adenosine deaminase complexing proteins of human tissues and body fluids. J Biol Chem. 1979 Dec 10;254(23):11958–11963. [PubMed] [Google Scholar]
  16. Trotta P. P., Balis M. E. Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor-specific variants. Biochemistry. 1978 Jan 24;17(2):270–278. doi: 10.1021/bi00595a013. [DOI] [PubMed] [Google Scholar]
  17. Trotta P. P. Identification of a membrane adenosine deaminase binding protein from human placenta. Biochemistry. 1982 Aug 17;21(17):4014–4023. doi: 10.1021/bi00260a017. [DOI] [PubMed] [Google Scholar]
  18. Ueda R., Ogata S., Morrissey D. M., Finstad C. L., Szkudlarek J., Whitmore W. F., Oettgen H. F., Lloyd K. O., Old L. J. Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5122–5126. doi: 10.1073/pnas.78.8.5122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wallace A. C., Nairn R. C. Renal tubular antigens in kidney tumors. Cancer. 1972 Apr;29(4):977–981. doi: 10.1002/1097-0142(197204)29:4<977::aid-cncr2820290444>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  20. ten Kate J., Wijnen J. T., van der Goes R. G., Quadt R., Griffioen G., Bosman F. T., Khan P. M. Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas. Cancer Res. 1984 Oct;44(10):4688–4692. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES